Loading...
Effects of mGluR5 Antagonists on Parkinson's Patients With L-Dopa-Induced Dyskinesia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Modulation of Metabotropic glutamate receptor 5 (mGluR5) may be a novel therapeutic approach to manage Parkinson's disease (PD) Patients with L-dopa-induced dyskinesia (LID). Objectives: The objective of this meta-analysis was to evaluate the effects of mGluR5 antagonists for the tr...
Na minha lista:
| Udgivet i: | Front Aging Neurosci |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6142875/ https://ncbi.nlm.nih.gov/pubmed/30271338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2018.00262 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|